KR100551778B1 - 티오펜 레티노이드 - Google Patents
티오펜 레티노이드 Download PDFInfo
- Publication number
- KR100551778B1 KR100551778B1 KR1020037000289A KR20037000289A KR100551778B1 KR 100551778 B1 KR100551778 B1 KR 100551778B1 KR 1020037000289 A KR1020037000289 A KR 1020037000289A KR 20037000289 A KR20037000289 A KR 20037000289A KR 100551778 B1 KR100551778 B1 KR 100551778B1
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- tetramethyl
- alkyl
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC(C)(*)C(C1)=C(C(C)(C)N)C=C(*)[C@@]1C=CC1=CC=C(*)CS1 Chemical compound CC(C)(*)C(C1)=C(C(C)(C)N)C=C(*)[C@@]1C=CC1=CC=C(*)CS1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00114767.7 | 2000-07-10 | ||
| EP00114767 | 2000-07-10 | ||
| PCT/EP2001/007506 WO2002004439A2 (en) | 2000-07-10 | 2001-06-30 | Thiophene retinoids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20030040350A KR20030040350A (ko) | 2003-05-22 |
| KR100551778B1 true KR100551778B1 (ko) | 2006-02-13 |
Family
ID=8169205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020037000289A Expired - Fee Related KR100551778B1 (ko) | 2000-07-10 | 2001-06-30 | 티오펜 레티노이드 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6403810B2 (enExample) |
| EP (1) | EP1301505A2 (enExample) |
| JP (1) | JP2004502767A (enExample) |
| KR (1) | KR100551778B1 (enExample) |
| CN (1) | CN1219777C (enExample) |
| AR (1) | AR029572A1 (enExample) |
| AU (2) | AU8961901A (enExample) |
| BR (1) | BR0112328A (enExample) |
| CA (1) | CA2414936C (enExample) |
| MX (1) | MXPA03000222A (enExample) |
| WO (1) | WO2002004439A2 (enExample) |
| ZA (1) | ZA200210049B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200510298A (en) * | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
| US7476673B2 (en) * | 2003-12-30 | 2009-01-13 | Allergan, Inc. | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors |
| US7250414B2 (en) * | 2004-03-11 | 2007-07-31 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| US20060161076A1 (en) * | 2005-01-06 | 2006-07-20 | Diamics, Inc. | Systems and methods for collection of cell clusters |
| US20060189893A1 (en) * | 2005-01-06 | 2006-08-24 | Diamics, Inc. | Systems and methods for detecting abnormal cells |
| US7781187B2 (en) * | 2005-12-30 | 2010-08-24 | Corning Incorporated | Fluorescent dyes |
| WO2008057930A2 (en) * | 2006-11-02 | 2008-05-15 | Aestus Therapeutics, Inc. | Methods of treating neuropathic pain with retinoic acid receptor agonists |
| WO2025109225A1 (en) | 2023-11-24 | 2025-05-30 | Etherna Immunotherapies Nv | Method for reducing dsrna formation during ivt |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4123469A (en) | 1977-06-30 | 1978-10-31 | International Flavors & Fragrances Inc. | Process for production of bicyclic compounds |
| US5324840A (en) * | 1992-06-11 | 1994-06-28 | Allergan, Inc. | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
| US5455265A (en) * | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
| US5399586A (en) | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
| US5475022A (en) * | 1993-10-18 | 1995-12-12 | Allergan, Inc. | Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
| FR2743560B1 (fr) * | 1996-01-17 | 1998-04-03 | Europ De Bioprospective Centre | Derives polycycliques aromatiques de type retinoide, leur procede de preparation et leur utilisation pour la fabrication de compositions pharmaceutiques et cosmetiques |
| FR2753091B1 (fr) | 1996-09-09 | 2001-03-16 | Oreal | Utilisation d'un agoniste des recepteurs des retinoides de type rxr pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute |
-
2001
- 2001-06-15 US US09/882,110 patent/US6403810B2/en not_active Expired - Fee Related
- 2001-06-30 MX MXPA03000222A patent/MXPA03000222A/es active IP Right Grant
- 2001-06-30 CN CNB01812660XA patent/CN1219777C/zh not_active Expired - Fee Related
- 2001-06-30 CA CA002414936A patent/CA2414936C/en not_active Expired - Fee Related
- 2001-06-30 AU AU8961901A patent/AU8961901A/xx active Pending
- 2001-06-30 EP EP01969328A patent/EP1301505A2/en not_active Withdrawn
- 2001-06-30 WO PCT/EP2001/007506 patent/WO2002004439A2/en not_active Ceased
- 2001-06-30 JP JP2002509304A patent/JP2004502767A/ja active Pending
- 2001-06-30 KR KR1020037000289A patent/KR100551778B1/ko not_active Expired - Fee Related
- 2001-06-30 AU AU2001289619A patent/AU2001289619B2/en not_active Ceased
- 2001-06-30 BR BR0112328-9A patent/BR0112328A/pt not_active IP Right Cessation
- 2001-07-06 AR ARP010103228A patent/AR029572A1/es unknown
-
2002
- 2002-12-11 ZA ZA200210049A patent/ZA200210049B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002004439A3 (en) | 2002-09-26 |
| KR20030040350A (ko) | 2003-05-22 |
| US6403810B2 (en) | 2002-06-11 |
| MXPA03000222A (es) | 2003-06-06 |
| AU2001289619B2 (en) | 2006-07-13 |
| BR0112328A (pt) | 2003-07-22 |
| CA2414936C (en) | 2006-12-05 |
| AR029572A1 (es) | 2003-07-02 |
| WO2002004439A2 (en) | 2002-01-17 |
| ZA200210049B (en) | 2004-03-11 |
| AU8961901A (en) | 2002-01-21 |
| CN1441798A (zh) | 2003-09-10 |
| JP2004502767A (ja) | 2004-01-29 |
| EP1301505A2 (en) | 2003-04-16 |
| CN1219777C (zh) | 2005-09-21 |
| CA2414936A1 (en) | 2002-01-17 |
| US20020019438A1 (en) | 2002-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU772551B2 (en) | New selective retinoid agonists | |
| EP1280757B1 (en) | New gamma selective retinoids | |
| KR100551778B1 (ko) | 티오펜 레티노이드 | |
| US6479670B1 (en) | Selective retinoid acid receptor agonists | |
| AU2001289619A1 (en) | Thiophene retinoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20090207 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20090207 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |